Variant report
Variant | esv3520039 |
---|---|
Chromosome Location | chr8:20781293-20784155 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544917060 | chr8:20781603-20781604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75525063 | chr8:20781611-20781612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545991460 | chr8:20781643-20781644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192286171 | chr8:20781647-20781648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531391869 | chr8:20781650-20781651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549894754 | chr8:20781651-20781652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74410180 | chr8:20781678-20781679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561823283 | chr8:20781681-20781682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4961408 | chr8:20781686-20781687 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs371033550 | chr8:20781723-20781724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115542383 | chr8:20781726-20781727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75274827 | chr8:20781790-20781791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185643042 | chr8:20781874-20781875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570304142 | chr8:20781920-20781921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538524224 | chr8:20781963-20781964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556770384 | chr8:20781979-20781980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556322612 | chr8:20781987-20781988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190568889 | chr8:20781991-20781992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574556662 | chr8:20781992-20781993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1020222 | chr8:20782074-20782075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148503922 | chr8:20782078-20782079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572310265 | chr8:20782102-20782103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182402577 | chr8:20782110-20782111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78146475 | chr8:20782170-20782171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575858123 | chr8:20782181-20782182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543183081 | chr8:20782189-20782190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556176451 | chr8:20782220-20782221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142821835 | chr8:20782225-20782226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs118173154 | chr8:20782244-20782245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs974153 | chr8:20782262-20782263 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs533353597 | chr8:20782315-20782316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146755237 | chr8:20782316-20782317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373822635 | chr8:20782344-20782345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531150703 | chr8:20782356-20782357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549568059 | chr8:20782389-20782390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371324566 | chr8:20782401-20782402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568174000 | chr8:20782534-20782535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535158945 | chr8:20782545-20782546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553829557 | chr8:20782563-20782564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73629658 | chr8:20782580-20782581 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs539396015 | chr8:20782591-20782592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557649262 | chr8:20782614-20782615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575895383 | chr8:20782616-20782617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543222148 | chr8:20782633-20782634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145407211 | chr8:20782661-20782662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573776158 | chr8:20782676-20782677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34177244 | chr8:20782677-20782678 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs559783699 | chr8:20782698-20782699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188213519 | chr8:20782802-20782803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545359111 | chr8:20782820-20782821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:20781600-20781800 | Enhancers | Primary hematopoietic stem cells | blood |
2 | chr8:20781600-20782400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr8:20781800-20782400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr8:20782400-20785400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr8:20782400-20785400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |